Health

Results: 7885-7896 of 8672

STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada's Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital. This national awards program recognizes best-in-class Canadian organizations for fostering high-performance corporate cultures that help sustain a competitive advantage. (Graphic: Business Wire)

STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award

AI-enabled Home Healthcare Provider Cera Care to Save the UK Government & Hospitals £100M This Winter by Committing to 5 Million Care Visits

Vertex Announces European Medicines Agency Validation for Marketing Authorization Application Extension for KAFTRIO® in Combination With Ivacaftor to Include People With Cystic Fibrosis and Responsive Rare Mutations

DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia

Calliditas' partner Everest Medicines announces China NMPA's approval of Nefecon® for the treatment of primary IgA nephropathy

European Commission Approves KAFTRIO® in Combination With Ivacaftor for the Treatment of Children With Cystic Fibrosis Ages 2 Through 5

Ellipses EP0031/A400 granted Orphan Drug Designation from the US Food and Drug Administration

PA Media Press Centres associated0

Fewer than three in ten people confident to deliver emergency CPR

Husband-and-wife founding partners of Biomel, Steven Hegarty and Janett Lozano.

IRIS Ventures Champions Biomel’s Next Generation Gut Health Movement with a £5.5 Million Investment

Trillium Health Partners to become first in Canada to deploy AI in diagnostic imaging using Sectra Amplifier Services

Nights On Lottie 2023: £1000+ Gifts Exclusively For UK Carers & Care Workers To Celebrate Carers Rights Day 2023

PR Newswire associated0

Bracco Announces Long-Term Strategic Partnership with ulrich medical for Syringeless Magnetic Resonance Injectors